| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/28/2009 | CN101355946A Compounds for modulating TRPV3 function |
| 01/28/2009 | CN101353328A Preparation of 2-chlorin-4-amido-6,7-dimethoxy quinazoline |
| 01/28/2009 | CN101353327A Aryl substituted pyrimidine spirobifluorene derivative and preparation thereof |
| 01/28/2009 | CN100455582C Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/27/2009 | US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 01/27/2009 | US7482360 Fused tetracyclic mGluR1 antagonists as therapeutic agents |
| 01/27/2009 | US7482357 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease |
| 01/27/2009 | US7482355 Pyrimidine derivatives as modulators of chemokine receptor activity |
| 01/27/2009 | US7482354 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 01/27/2009 | US7482351 Against breast, colon, pancreatic, lung, bone, or renal tumor cells; antimetastasis agents; administered orally or intravenously; combined with chemotherapy to reduce generation of drug resistance |
| 01/27/2009 | US7482350 4,5-disubstituted-2-aryl pyrimidines |
| 01/27/2009 | US7482346 Carboxylation of the alkylpiperazine; amidation of the carbamate-ester; cannabinoid and vanilloid receptor antagonists |
| 01/27/2009 | US7482343 Mitotic kinesin KSP inhibitors; antiproliferative agents; 2-methylpyrimidin-4-ones |
| 01/27/2009 | US7482308 2-fluoro-6-[(4,6-dimethoxypyrimidin-2-yl)hydroxymethyl]-N-difluoromethanesulfonanilide; controlling paddy crop weeds; reacting 2-Chloro-6-[(4,6-dimethoxypyrimidin-2-yl)methyl]aniline with difluoromethanesulfonyl chloride |
| 01/27/2009 | US7481847 Dye composition comprising at least one cationic hydrazone direct dye, dyeing process, and multi-compartment devices |
| 01/27/2009 | CA2388646C Methods and compositions utilizing quinazolinones |
| 01/27/2009 | CA2361605C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 01/27/2009 | CA2309111C Process for the preparation of vinyl pyrimidine derivatives |
| 01/27/2009 | CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators |
| 01/22/2009 | WO2009012421A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/22/2009 | WO2009011285A1 Heteroarylbenzene compounds |
| 01/22/2009 | WO2008142550A3 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors |
| 01/22/2009 | WO2008084493A3 A novel process for the preparation of 2-halo-4-aminoquinazolines |
| 01/22/2009 | WO2008052737A3 Immunochemically equivalent hiv drug analogs |
| 01/22/2009 | WO2007133773A3 Identification of cdki pathway inhibitors |
| 01/22/2009 | US20090023923 1-(4-Bromo-3-methyphenyl)-3-(3,5-dichlorophenyl)-3-hydroxy-4,4,4-trifluorobutane-1-one; -(4-Bromo-3-methylphenyl)-3-(3,5-dichlorophenyl)-4,4,4-trifluoro-2-butene-1-one; chemical intermediates for agricultural pesticides, insecticides |
| 01/22/2009 | US20090023774 Pyridine analogs as C5A antagonists |
| 01/22/2009 | US20090023762 Substituted 2-Aminopyrimidine-4-Ones, Their Pharmaceutical Compositions And Their Use In The Treatment And/Or Prevention Of Ab-Related Pathologies |
| 01/22/2009 | US20090023760 anticarcinogenic agent; thymidylate synthase (TS) inhibitors; Tri-tert-butyl N-{N-{4-[N-((6RS)-2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamate |
| 01/22/2009 | US20090023734 Treating cell proliferative disorders |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023729 Trisubstituted amine compound |
| 01/22/2009 | US20090023710 Compound |
| 01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
| 01/22/2009 | US20090023085 Photosensitive Compositions, Curable Compositions, Novel Compounds, Photopolymerizable Compositions, Color Filters, and Planographic Printing Plate Precursors |
| 01/22/2009 | CA2694475A1 Quinazolinamide derivatives |
| 01/22/2009 | CA2693594A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/21/2009 | EP2017267A1 Synthesis of statins |
| 01/21/2009 | EP1444211B1 Quinazoline derivatives as antitumor agents |
| 01/21/2009 | CN101351453A 杂环酰胺化合物及其用途 The heterocyclic amide compounds and use thereof |
| 01/21/2009 | CN101351452A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 01/21/2009 | CN101351451A Multicyclic amino acid derivatives and methods of their use |
| 01/21/2009 | CN101348471A Process for the preparation of 4- (3'chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
| 01/21/2009 | CN101348467A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 01/21/2009 | CN101348466A Preparation of N-{4-[3-chloro-4-(3-fluoro-benzyloxy)-anilino]-quinazoline-6-yl}-acrylamide |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN100453535C 2-substituted pyrimidines. |
| 01/21/2009 | CN100453534C Substituted dihydropyrimidinone preparation using polyaniline salt catalyst |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/20/2009 | US7479560 Creatine pyroglutamic acid salts and methods for their production and use in individuals |
| 01/20/2009 | US7479558 Chemical intermediates |
| 01/20/2009 | US7479495 N-heterocyclic inhibitors of TNF-α expression |
| 01/20/2009 | US7479494 3-monosubstituted tropane derivatives as nociceptin receptor ligands |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/20/2009 | CA2283585C Substituted tetrahydropyrimidine derivatives and their use as polymerization inhibitors for vinyl aromatic compounds |
| 01/15/2009 | WO2009009152A1 Rosuvastatin intermediates and their preparation |
| 01/15/2009 | WO2009008371A1 Di(arylamino)aryl compound |
| 01/15/2009 | WO2009008353A1 Chrysene derivative and organic el device |
| 01/15/2009 | WO2009007984A2 An improved process for erlotinib hydrochloride |
| 01/15/2009 | WO2009007750A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 01/15/2009 | WO2009007441A2 Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile |
| 01/15/2009 | WO2008142140A3 Novel 2,3-diamino-quinazolinone derivatives and their medical use |
| 01/15/2009 | WO2008119810A3 Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof |
| 01/15/2009 | US20090018150 5-Ht2b Receptor Antagonists |
| 01/15/2009 | US20090018056 Heteroarylcarbamoylbenzene derivatives |
| 01/15/2009 | US20090017003 Thiosulfonate anti-inflammatory agents |
| 01/15/2009 | DE102007032739A1 Chinazolinamidderivate Chinazolinamidderivate |
| 01/15/2009 | CA2695330A1 Inhibitors of akt/pkb with anti-tumor activity |
| 01/15/2009 | CA2693044A1 Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile |
| 01/15/2009 | CA2692783A1 Quinazolinone t-type calcium channel antagonists |
| 01/15/2009 | CA2692720A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 01/15/2009 | CA2692611A1 Di(arylamino)aryl compounds |
| 01/15/2009 | CA2687750A1 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
| 01/14/2009 | EP2014285A1 NPYY5 antagonists |
| 01/14/2009 | EP2013189A1 Dhfr enzyme inhibitors |
| 01/14/2009 | EP2013188A1 Rosuvastatin zinc salt |
| 01/14/2009 | EP2013179A1 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 01/14/2009 | EP2012799A2 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates |
| 01/14/2009 | EP1898917B1 Aminopyrimidines as kinase modulators |
| 01/14/2009 | EP1233948B1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 01/14/2009 | CN101346357A Aminodihydrothiazine derivative |
| 01/14/2009 | CN101346356A Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 01/14/2009 | CN101343253A 2-amido-4, 5-diaryl miazines compound, preparation and pharmaceutical use thereof |
| 01/14/2009 | CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors |
| 01/14/2009 | CN100451006C Carboxyl acylamide compound and its preparing method and use |
| 01/14/2009 | CN100451004C Novel quinoline,Tetrahydroquinazoline,And pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 01/08/2009 | WO2009006569A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 01/08/2009 | WO2009006086A2 A new process for preparing 2-(3-{6-[2-(2,4-dichlorophenyl)-ethylamino]-2-methoxypyrimidin-4-yl}-phenyl)- 2-methylpropionic acid |
| 01/08/2009 | WO2009005693A1 Novel hiv reverse transcriptase inhibitors |
| 01/08/2009 | WO2009005674A2 Novel hiv reverse transcriptase inhibitors |
| 01/08/2009 | WO2009004653A2 Process for preparing an amorphous form of (2s,3s,5s)-2-(2,6- dimethylphenoxyacetyl)-amino-3-hydroxy-5-(2-(1-tetrahydropyrimid-2-only)-3-methylbutanoyl)-amino-1,6-diphenyl hexane and product thereof |
| 01/08/2009 | WO2009004374A1 Process for introduction of hydroxyethoxy side chain in bosentan |
| 01/08/2009 | WO2009003590A1 A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 01/08/2009 | WO2008142720A3 Quinazolin-oxime derivatives as hsp90 inhibitors |
| 01/08/2009 | WO2008125891A3 Pyrimidinyl-piperazines useful as dopamine d3 /d2 receptor ligands |
| 01/08/2009 | WO2008119457A3 Lactam-substituted dicarboxylic acids and use thereof |